Long-term Efficacy and Safety of Subcutaneous Tocilizumab in Patients with Polyarticular or Systemic Juvenile Idiopathic Arthritis - an Extension Study of 2 Phase 1b Clinical Trials

被引：0
|
作者：
Brunner, Hermine [1 ]
Ramanan, Athimalaipet [2 ]
Horneff, Gerd [3 ]
Minden, Kirsten [4 ]
Calvo Penades, Inmaculada [5 ]
Zucchetto, Mauro [6 ]
Brockwell, Laura [7 ]
Gordon, Oliver [7 ]
De Benedetti, Fabrizio [8 ]
机构：
[1] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Rheumatol, Dept Pediat, Cincinnati, OH USA
[2] Bristol Royal Hosp Children, Bristol, Avon, England
[3] Asklepios Klin Sankt Augustin GmbH, Pediat, St Augustin, Germany
[4] Charite Univ Med Berlin, Berlin, Germany
[5] Hosp Univ Politecn, Pediat Rheumatol Unit, Valencia, Spain
[6] Parexel Int, Milan, Italy
[7] Roche Prod Ltd, Welwyn Garden City, Herts, England
[8] Osped Pediat Bambino Gesu, IRCCS, Div Rheumatol, Rome, Italy
来源：
ARTHRITIS & RHEUMATOLOGY | 2022年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2212
引用
收藏
页码：4390 / 4393
页数：4
相关论文
共 50 条
  • [21] Efficacy and safety of tocilizumab in a real-life observational cohort of patients with polyarticular juvenile idiopathic arthritis
    Gronlund, Minna-Maija
    Remes-Pakarinen, Terhi
    Kroger, Liisa
    Markula-Patjas, Kati
    Backstrom, Maria
    Putto-Laurila, Anne
    Aalto, Kristiina
    Vahasalo, Paula
    RHEUMATOLOGY, 2020, 59 (04) : 732 - 741
  • [22] Efficacy and Safety of Tocilizumab in Patients with Systemic Juvenile Idiopathic Arthritis: 2-Year Data From a Phase III Clinical Trial
    De Benedetti, Fabrizio
    Brunner, Hermine
    Ruperto, Nicolino
    Kenwright, Andrew
    Devlin, Clare
    Calvo, Inmaculada
    Cuttica, Ruben
    Ravelli, Angelo
    Schneider, Rayfel
    Eleftheriou, Despina
    Wouters, Carine H.
    Xavier, Ricardo
    Zemel, Lawrence S.
    Baildam, Eileen M.
    Burgos-Vargas, Ruben
    Dolezalova, Pavla
    Garay, Stella Maris
    Joos, Rik
    Grom, Alexei
    Wulffraat, Nico
    Zuber, Zbigniew
    Zulian, Francesco
    Martini, Alberto
    Lovell, Daniel
    ARTHRITIS AND RHEUMATISM, 2011, 63 (12): : 4047 - 4047
  • [23] Efficacy and safety of tocilizumab in Chinese patients with systemic juvenile idiopathic arthritis: a multicentre phase IV trial
    Li, Caifeng
    Tang, Xuemei
    Zhou, Zhixuan
    Sun, Li
    Lu, Meiping
    Zhou, Wei
    Yang, Sirui
    Zheng, Wenjie
    Yu, Haiguo
    Tan, Weiping
    Zhang, Junmei
    Zhang, Yu
    Kong, Yuxiu
    Xu, Jiahui
    CLINICAL RHEUMATOLOGY, 2024, 43 (11) : 3457 - 3467
  • [24] Pharmacokinetics and pharmacodynamics of long-term tocilizumab therapy in patients with systemic juvenile idiopathic arthritis.
    De Benedetti, Fabrizio
    Brunner, Hermine
    Fettner, Scott
    Keane, Caroline
    Devlin, Clare
    Wang, Jianmei
    Ruperto, Nicolino
    PHARMACOTHERAPY, 2013, 33 (10): : E234 - E234
  • [25] Long-term Safety Profile of Anakinra in Patients with Systemic Juvenile Idiopathic Arthritis
    Giancane, Gabriella
    Papa, Riccardo
    Vastert, Sebastiaan
    Bagnasco, Francesca
    Swart, Joost
    Quartier, Pierre
    Anton, Jordi
    Paut, Isabelle Kone
    Kamphuis, Sylvia
    Herlin, Troels
    Sanner, Helga
    De Benedetti, Fabrizio
    Tsitsami, Elena
    Nielsen, Susan Mary
    Moreno, Estefania
    Pallotti, Chiara
    Franck-Larsson, Karin
    Malmstrom, Hakan
    Cederholm, Susanna
    Raat, Nico Wulff
    Ruperto, Nicolino
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [26] Long-Term Safety and Efficacy of Subcutaneously Administered Tocilizumab for Adult Rheumatoid Arthritis: A Multicenter Phase 3b Long-term Extension Study
    Kivitz A.
    Wallace T.
    Olech E.
    Borofsky M.
    Devenport J.
    Pei J.
    Michalska M.
    Rheumatology and Therapy, 2016, 3 (2) : 291 - 304
  • [27] Long-term Efficacy and Safety of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA): Results From a Phase III
    Brunner, Hermine
    Ruperto, Nicolino
    Quartier, Pierre
    Constantin, Tamas
    Alexeeva, Ekaterina
    Kone-Paut, Isabelle
    Marzan, Katherine
    Wulffraat, Nico
    Schneider, Rayfel
    Padeh, Shai
    Chasnyk, Vyacheslav
    Wouters, Carine
    Kuemmerle-Deschner, Jasmin B.
    Kallinich, Tilmann
    Lauwerys, Bernard
    Haddad, Elie
    Nasonov, Evgeny L.
    Trachana, Maria
    Vougiouka, Olga
    Leon, Karolynn
    Vritzali, Eleni
    Lheritier, Karine
    Martini, Alberto
    Lovell, Daniel
    ARTHRITIS & RHEUMATOLOGY, 2017, 69 : 64 - 66
  • [28] SAFETY AND EFFICACY OF TOCILIZUMAB IN PATIENTS WITH POLYARTICULAR COURSE JUVENILE IDIOPATHIC ARTHRITIS: RESULT FROM LONG-TERM, INTERVENTIONAL, OPEN LABEL EXTENSION STUDY IN PATIENTS FROM POLAND AND RUSSIA WHO COMPLETED THE GLOBAL, MULTINATIONAL TRIAL (CHERISH STUDY)
    Opoka-Winiarska, V.
    Smolewska, E.
    Zuber, Z.
    Debowska, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 394 - 394
  • [29] Long-Term Safety of Tocilizumab in Rheumatoid Arthritis Clinical Trials.
    Genovese, Mark C.
    Sebba, Anthony
    Rubbert-Roth, Andrea
    Scali, Juan
    Zilberstein, Moshe
    Thompson, Liz
    van Vollenhoven, Ronald F.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S866 - S866
  • [30] Long-Term Safety of Adalimumab Treatment in Pediatric Patients with Polyarticular Juvenile Idiopathic Arthritis and Enthesitis-Related Arthritis
    Lovell, Daniel
    Ruperto, Nicolino
    Kingsbury, Daniel J.
    Burgos-Vargas, Ruben
    Imagawa, Tomoyuki
    Horneff, G.
    Quartier, Pierre
    Goodman, Steven
    Reiff, Andreas
    Giannini, Edward H.
    Cardoso, Anabela
    Anderson, Jaclyn K.
    Varothai, Nupun A.
    Kalabic, Jasmina
    Martini, Alberto
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
12345